Final results of a long-term, clinical follow-up in fatty liver patients

Sanne Dam-Larsen; Ulrik Becker; Maria-Benedicte Franzmann; Klaus Larsen; Per Christoffersen; Flemming Bendtsen; Sanne Dam-Larsen; Ulrik Becker; Maria-Benedicte Franzmann; Klaus Larsen; Per Christoffersen; Flemming Bendtsen

doi:10.1080/00365520903171284

Final results of a long-term, clinical follow-up in fatty liver patients

Sanne Dam-Larsen, Ulrik Becker, Maria-Benedicte Franzmann, Klaus Larsen, Per Christoffersen, Flemming Bendtsen, Sanne Dam-Larsen, Ulrik Becker, Maria-Benedicte Franzmann, Klaus Larsen, Per Christoffersen, Flemming Bendtsen

143 Citations (Scopus)

Abstract

OBJECTIVE: There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. MATERIAL AND METHODS: Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death. All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. RESULTS: The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients (1.2%) developed cirrhosis during the follow-up period versus 54 (22%) AFLD patients. Sixty-four percent of 178 surviving patients out of an original cohort of 417 patients attended the clinical follow-up. In NAFLD patients, none of the risk factors studied was significant in relation to the risk of death. Patients with AFLD died primarily from cirrhosis and other alcohol-related disorders, whereas in patients with NAFLD the main causes of death were cardiovascular disease and cancer. CONCLUSIONS: For patients with pure non-alcoholic fatty liver, survival was good and independent of the histological, clinical and biochemical characteristics at the time of biopsy; the main causes of death were cardiovascular disease and cancer.

Original language	English
Journal	Scandinavian Journal of Gastroenterology
Volume	44
Issue number	10
Pages (from-to)	1236-43
Number of pages	7
ISSN	0036-5521
DOIs	https://doi.org/10.1080/00365520903171284 https://doi.org/10.1080/00365520903171284
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Cite this

Dam-Larsen, S., Becker, U., Franzmann, M-B., Larsen, K., Christoffersen, P., Bendtsen, F., Dam-Larsen, S., Becker, U., Franzmann, M-B., Larsen, K., Christoffersen, P., & Bendtsen, F. (2009). Final results of a long-term, clinical follow-up in fatty liver patients. Scandinavian Journal of Gastroenterology, 44(10), 1236-43. https://doi.org/10.1080/00365520903171284, https://doi.org/10.1080/00365520903171284

Dam-Larsen, S, Becker, U, Franzmann, M-B, Larsen, K, Christoffersen, P, Bendtsen, F, Dam-Larsen, S, Becker, U, Franzmann, M-B, Larsen, K, Christoffersen, P & Bendtsen, F 2009, 'Final results of a long-term, clinical follow-up in fatty liver patients', Scandinavian Journal of Gastroenterology, vol. 44, no. 10, pp. 1236-43. https://doi.org/10.1080/00365520903171284, https://doi.org/10.1080/00365520903171284

@article{4c83bdc0aabc11df928f000ea68e967b,

title = "Final results of a long-term, clinical follow-up in fatty liver patients",

abstract = "OBJECTIVE: There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. MATERIAL AND METHODS: Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death. All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. RESULTS: The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients (1.2%) developed cirrhosis during the follow-up period versus 54 (22%) AFLD patients. Sixty-four percent of 178 surviving patients out of an original cohort of 417 patients attended the clinical follow-up. In NAFLD patients, none of the risk factors studied was significant in relation to the risk of death. Patients with AFLD died primarily from cirrhosis and other alcohol-related disorders, whereas in patients with NAFLD the main causes of death were cardiovascular disease and cancer. CONCLUSIONS: For patients with pure non-alcoholic fatty liver, survival was good and independent of the histological, clinical and biochemical characteristics at the time of biopsy; the main causes of death were cardiovascular disease and cancer.",

author = "Sanne Dam-Larsen and Ulrik Becker and Maria-Benedicte Franzmann and Klaus Larsen and Per Christoffersen and Flemming Bendtsen and Sanne Dam-Larsen and Ulrik Becker and Maria-Benedicte Franzmann and Klaus Larsen and Per Christoffersen and Flemming Bendtsen",

note = "Keywords: Adult; Aged; Aged, 80 and over; Biopsy; Cause of Death; Fatty Liver; Fatty Liver, Alcoholic; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Risk Factors; Time Factors",

year = "2009",

doi = "10.1080/00365520903171284",

language = "English",

volume = "44",

pages = "1236--43",

journal = "Scandinavian Journal of Gastroenterology",

issn = "0036-5521",

publisher = "Taylor & Francis",

number = "10",

}

TY - JOUR

T1 - Final results of a long-term, clinical follow-up in fatty liver patients

AU - Dam-Larsen, Sanne

AU - Becker, Ulrik

AU - Franzmann, Maria-Benedicte

AU - Larsen, Klaus

AU - Christoffersen, Per

AU - Bendtsen, Flemming

AU - Dam-Larsen, Sanne

AU - Becker, Ulrik

AU - Franzmann, Maria-Benedicte

AU - Larsen, Klaus

AU - Christoffersen, Per

AU - Bendtsen, Flemming

N1 - Keywords: Adult; Aged; Aged, 80 and over; Biopsy; Cause of Death; Fatty Liver; Fatty Liver, Alcoholic; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Risk Factors; Time Factors

PY - 2009

Y1 - 2009

N2 - OBJECTIVE: There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. MATERIAL AND METHODS: Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death. All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. RESULTS: The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients (1.2%) developed cirrhosis during the follow-up period versus 54 (22%) AFLD patients. Sixty-four percent of 178 surviving patients out of an original cohort of 417 patients attended the clinical follow-up. In NAFLD patients, none of the risk factors studied was significant in relation to the risk of death. Patients with AFLD died primarily from cirrhosis and other alcohol-related disorders, whereas in patients with NAFLD the main causes of death were cardiovascular disease and cancer. CONCLUSIONS: For patients with pure non-alcoholic fatty liver, survival was good and independent of the histological, clinical and biochemical characteristics at the time of biopsy; the main causes of death were cardiovascular disease and cancer.

AB - OBJECTIVE: There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. MATERIAL AND METHODS: Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death. All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. RESULTS: The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients (1.2%) developed cirrhosis during the follow-up period versus 54 (22%) AFLD patients. Sixty-four percent of 178 surviving patients out of an original cohort of 417 patients attended the clinical follow-up. In NAFLD patients, none of the risk factors studied was significant in relation to the risk of death. Patients with AFLD died primarily from cirrhosis and other alcohol-related disorders, whereas in patients with NAFLD the main causes of death were cardiovascular disease and cancer. CONCLUSIONS: For patients with pure non-alcoholic fatty liver, survival was good and independent of the histological, clinical and biochemical characteristics at the time of biopsy; the main causes of death were cardiovascular disease and cancer.

U2 - 10.1080/00365520903171284

DO - 10.1080/00365520903171284

M3 - Journal article

C2 - 19670076

SN - 0036-5521

VL - 44

SP - 1236

EP - 1243

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

IS - 10

ER -

Final results of a long-term, clinical follow-up in fatty liver patients

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this